Literature DB >> 1404386

Structural requirements for viroid processing by RNase T1.

G Steger1, T Baumstark, M Mörchen, M Tabler, M Tsagris, H L Sänger, D Riesner.   

Abstract

Viroids are replicated via a rolling circle-like mechanism in which (+) strand oligomeric intermediates have to be cleaved enzymatically to unit-length molecules followed by ligation to mature circles. A transcript of potato spindle tuber viroid, which is still infectious, consists of a monomeric molecule with only 22 additional nucleotides, thus doubling part of the central conserved region of viroids. It was shown that this transcript can be cleaved and ligated in vitro to circles by RNase T1. To elucidate the site and mechanism of processing, 16 different site-specific mutants of this longer-than-unit-length transcript were constructed and analyzed by in vitro processing with RNase T1, infectivity studies, temperature-gradient gel electrophoresis, and structure calculations. The wild-type sequence and several mutated transcripts are able to adopt a particular secondary structure which is the prerequisite for enzymatic cleavage and ligation by RNase T1. This "processing structure" exposes both potential cleavage sites in the nearest spatial neighborhood, thus favoring the subsequent ligation to circles. Those mutated sequences for which the formation of the processing structure is impossible or thermodynamically highly unfavored are not processed. The results demonstrate that the particular structural features of viroids enable them to be cleaved and ligated by one and the same enzyme, RNase T1. The in vitro mechanism may serve as a mechanistic model for cellular processing of viroids.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1404386     DOI: 10.1016/0022-2836(92)90220-e

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  12 in total

1.  Compilation and analysis of viroid and viroid-like RNA sequences.

Authors:  F Bussière; D Lafontaine; J P Perreault
Journal:  Nucleic Acids Res       Date:  1996-05-15       Impact factor: 16.971

2.  Precisely full length, circularizable, complementary RNA: an infectious form of potato spindle tuber viroid.

Authors:  P A Feldstein; Y Hu; R A Owens
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

Review 3.  Plant pathogenic RNAs and RNA catalysis.

Authors:  R H Symons
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

Review 4.  RNA structure and the regulation of gene expression.

Authors:  P Klaff; D Riesner; G Steger
Journal:  Plant Mol Biol       Date:  1996-10       Impact factor: 4.076

5.  The brome mosaic virus RNA3 intergenic replication enhancer folds to mimic a tRNA TpsiC-stem loop and is modified in vivo.

Authors:  T Baumstark; P Ahlquist
Journal:  RNA       Date:  2001-11       Impact factor: 4.942

6.  Only one of four possible secondary structures of the central conserved region of potato spindle tuber viroid is a substrate for processing in a potato nuclear extract.

Authors:  T Baumstark; D Riesner
Journal:  Nucleic Acids Res       Date:  1995-11-11       Impact factor: 16.971

7.  A mini-RNA containing the tetraloop, wobble-pair and loop E motifs of the central conserved region of potato spindle tuber viroid is processed into a minicircle.

Authors:  O Schrader; T Baumstark; D Riesner
Journal:  Nucleic Acids Res       Date:  2003-02-01       Impact factor: 16.971

8.  Specific RNA self-cleavage in coconut cadang cadang viroid: potential for a role in rolling circle replication.

Authors:  Y H Liu; R H Symons
Journal:  RNA       Date:  1998-04       Impact factor: 4.942

9.  Processing of Potato Spindle Tuber Viroid RNAs in Yeast, a Nonconventional Host.

Authors:  Dillon Friday; Priyadarshini Mukkara; Robert A Owens; Tilman Baumstark; Michael F Bruist
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

10.  An infectious viroid RNA replicon evolved from an in vitro-generated non-infectious viroid deletion mutant via a complementary deletion in vivo.

Authors:  M Wassenegger; S Heimes; H L Sänger
Journal:  EMBO J       Date:  1994-12-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.